Enzon Pharmaceuticals Stock News

You'll often hear people say that bear markets are great for finding bargains, and that's true. With the exception of energy, every major sector is in the red for the year.

Icosavax (NASDAQ:ICVX) and Enzon Pharmaceuticals (OTCMKTS:ENZN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations for Icosavax and Enzon Pharmaceuticals, as reported []

Enzon Pharmaceuticals (OTCMKTS:ENZN) and Icosavax (NASDAQ:ICVX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Analyst Recommendations This is a summary of current ratings and price targets for Enzon Pharmaceuticals and [] The post Enzon Pharmaceuticals (OTCMKTS:ENZN) & Icosavax (NASDAQ:ICVX) Head-To-Head Contrast appeared first on ETF Daily News .

Enzon Pharmaceuticals (OTCMKTS: ENZN) is one of 232 public companies in the Biological products, except diagnostic industry, but how does it contrast to its competitors? We will compare Enzon Pharmaceuticals to related companies based on the strength of its dividends, institutional ownership, profitability, earnings, risk, valuation and analyst recommendations. Analyst Recommendations This is a summary []

Enzon Pharmaceuticals (OTCMKTS: ENZN) is one of 232 publicly-traded companies in the Biological products, except diagnostic industry, but how does it compare to its peers? We will compare Enzon Pharmaceuticals to related companies based on the strength of its profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Valuation and Earnings This table compares []

CRANFORD, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire from his role as the Com